ABSTRACT
OBJECTIVE: To investigate the value of texture analysis in magnetic resonance images for the evaluation of Gleason scores (GS) of prostate cancer. METHODS: Sixty-six prostate cancer patients are retrospective enrolled, which are divided into five groups namely, GSâ=â6, 3â+â4, 4â+â3, 8 and 9-10 according to postoperative pathological results. Extraction and analysis of texture features in T2-weighted MR imaging defined tumor region based on pathological specimen after operation are performed by texture software OmniKinetics. The values of texture are analyzed by single factor analysis of variance (ANOVA), and Spearman correlation analysis is used to study the correlation between the value of texture and Gleason classification. Receiver operating characteristic (ROC) curve is then used to assess the ability of applying texture parameters to predict Gleason score of prostate cancer. RESULTS: Entropy value increases and energy value decreases as the elevation of Gleason score, both with statistical difference among five groups (Fâ=â10.826, Fâ=â2.796, Pâ<â0.05). Energy value of group GSâ=â6 is significantly higher than that of groups GSâ=â8 and 9-10 (Pâ<â0.005), which is similar between three groups (GSâ=â3â+â4, 8 and 9-10). The entropy and energy values correlate with GS (râ=â0.767, râ=â-0.692, Pâ<â0.05). Areas under ROC curves (AUC) of combination of entropy and energy are greater than that of using energy alone between groups GSâ=â6 and ≥7. Analogously, AUC of combination of entropy and energy are significantly higher than that of using entropy alone between groups GS≤3â+â4 and ≥4â+â3, as well as between groups GS≤4â+â3 and ≥8. CONCLUSION: Texture analysis on T2-weighted images of prostate cancer can evaluate Gleason score, especially using the combination of entropy and energy rendering better diagnostic efficiency.
Subject(s)
Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Prostatic Neoplasms/diagnostic imaging , Aged , Humans , Male , Middle Aged , Neoplasm Grading , Prostate/diagnostic imaging , ROC CurveABSTRACT
Transcription factor II B (TFIIB)related factor 2 (BRF2) is involved in the development of cancer, but its role in lung cancer is underreported. The present study aimed to explore the role of BRF2 in the regulation of lung cancer cells. Immunofluorescence staining and immunohistochemistry were performed to detect BRF2 protein expression in human lung cancer cells and tissues. Following cell transfection with small interfering RNA for silencing BRF2, the cell proliferation was examined by Cell Counting Kit8 and MTT assays. Cell apoptosis, migration and invasion were determined by flow cytometry, woundhealing and Transwell assay. The expression levels of Akt, phosphorylated (p)Akt, Bax, Ecadherin, Bcl2, Ncadherin, Snail and epidermal growth factor receptor (EGFR) in human lung cancer A549 cells were detected by western blotting. The results demonstrated that BRF2 expression was increased in human lung cancer cells and tissues, and that silencing of BRF2 promoted cell apoptosis but inhibited cell proliferation and migration. The protein expression levels of Akt, Ecadherin, pAkt, Bcl2, Ncadherin, Snail and EGFR in A549 cells were inhibited by silencing of BRF2, while expression levels of Bax and Ecadherin were increased by silencing BRF2. In conclusion, BRF2 demonstrates high expression in lung cancer and silencing of BRF2 inhibits the growth and metastasis of lung cancer cells. The current findings provide a novel approach for the treatment of lung cancer.